N. Yangieva, D. Tuychibaeva
Age-related macular degeneration (AMD) is one of the leading medical and social problems worldwide. The purpose of this study was to evaluate the effectiveness of drug therapy in patients with early AMD with a lutein-zeaxanthin containing vitamin-mineral complex. The clinical study included 50 patients of the main group who took lutein-zeaxanthin containing a vitamin-mineral complex, 1 capsule once a day for 3 months, for 3 onsecutive years, and 50 patients of the control group who did not receive drug therapy. The patients of the main group showed an increase in visual acuity, an improvement in parameters according to OCT data, an improvement in the subjective perception of their own visual functions. At the same time, patients in the control group showed deterioration in visual acuity, progression of the disease according to OCT data, which was manifested by the transition to the next stage of AMD. Conclusion: drug therapy for early stage AMD has a prophylactic effect on the progression of the pathological process in the macular zone.